Administració i Direcció d'Empreses
. IESE Universidad de Navarra
. 01/11/2005
. (Specialized Training)Química
. Universitat de Barcelona
. 08/09/1987
. (Ph.D.)Química
. Universitat de Barcelona
. 22/11/1983
. (Diploma / Degree / Activities)
Research interests
Design and development of new experimental models for the study of potential anti-inflammatory and anti-asthmatic drugsDiscovery and characterization of mechanisms of action of new analgesic, anti-inflammatory and antiasthmatic drugsDiscovery, characterization of mechanisms of action and development of new drugs (antibiotics, antidiabetics, antihypertensives and drugs with action in the central nervous system)Development of active ingredients, drugs and new pharmaceutical forms
Journal Publications
Cabré, F.; Camacho, J.A.; Rodríguez-Garcés, C.A.; Breier, D.V.; Ballarin, M.(2023).
Review of Topical Sodium Heparin 1000 IU/g Gel in Symptomatic Uncomplicated Superficial Thrombophlebitis.Cureus Editorial Board, 15(10)
. https://doi.org/10.7759/cureus.47418. ISSN: 2168-8184Cánovas M, Polonio F, Cabré F.(2016).
Bioequivalence Study of Two Orodispersible Rizatriptan Formulations of 10 mg in Healthy Volunteers.Scientiae Pharmaceuticae, 84(3), pp. 514 - 522Palomer A., Pascual J., Cabré F., García M.L., Mauleón D.(2000).
Derivation of Pharmacophore and CoMFA models for the Leukotriene D4 receptor antagonists of quinolinyl(bridge)aryl serie.Journal of Medicinal Chemistry, 43, pp. 392 - 400. ISSN: 0022-2623Palomer A.; Pascual J.; Cabré M.; Borràs L.; González G.; Aparici M.; Carabaza A.; Cabré F.; García M.L.; Mauleón D(2002).
Structure-based design of cyclooxygenase-2 selectivity into ketoprofen.Bioorganic & Medicinal Chemistry Letters, 12, pp. 533 - 537. ISSN: 0960-894XPalomer A., Cabré F., Pascual J., Campos J., Trujillo M.A., García L., Mauleón D., Espinosa A.(2002).
Identification of Novel Cyclooxygenase-2 Selective Inhibitors Using Pharmacophore Models.Journal of Medicinal Chemistry, 45, pp. 1402 - 1411. ISSN: 0022-2623Cabré F., Carabaza A., García A.M., Calvo L., Cucchi P., Palomer A., Pascual J., García M.L., Manzini S., Lecci A, Crea A., Maggi C.A.(2002).
Pharmacological profile of MEN91507, a new leukotriene D4 receptor (Cys-LT1) antagonist.European Journal of Pharmacology, 451, pp. 317 - 326. ISSN: 0014-2999Diaz-Reval M.I., Ventura-Martinez R., Deciga-Campos M., Terron J.A., Cabré F., Lopez-Munoz F.J.(2004).
Evidence for a central mechanism of action of S-(+)-ketoprofen.European Journal of Pharmacology, 483, pp. 241 - 248. ISSN: 0014-2999Cánovas M, Cabré F, Polonio F(2014).
Bioequivalence study of two oral formulations of irbesartan 300 mg in healthy volunteers.Drug Research, 64(1), pp. 53 - 56. ISSN: 2194-9379Carabaza, A., Cabré, F., Rotllan, E., Gómez, M., Gutiérrez, M., García, M.L., Mauleón, D(1996).
Stereoselective inhibition of inducible cyclooxygenase by chiral non steroidal antiinflammatory drugs.Journal of Clinical Pharmacology, 36, pp. 505 - 512. ISSN: 0091-2700Cabré, F., Fernández, M.F., Calvo, L., Ferrer, X., García, M.L., Mauleón, D.(1998).
Analgesic, antiinflammatory and antipyretic effects of S(+)-ketoprofen in vivo.Journal of Clinical Pharmacology, 38(Supp), pp. 3S - 9S. ISSN: 0091-2700
Others Publications
Palomer, A., Giolitti, A., García, M.L., Cabré, F., Mauleón D., Carganico, G.(1995).
Molecular modeling and CoMFA investigations on LTD4 receptor antagonists
. In
QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications
. (pp. 444 - 450)
. Prous Science Publishers
.
Relevant Activities
Scientific & technical management of portfolio and pipeline of new products. Advice and consultancy in drug registrationScientific and technical advice in the management on the portfolio and pipeline of active pharmaceutical ingredients and in development of potential drug candidates for developmentDirector of Pharmaceutical RΔ Finished Dosage Forms (FDF) and Active Pharmaecutical Ingredients (API)Director of Pharmacological Research in Pharmaceutical R&DAccreditation Research in the field of Medical & Health Sciences by the Quality Agency of the University System of Catalonia (AQU)